June 2021 - Page 3 of 6 - BioMedWire (BMW)

ThursdayJun 17, 2021 10:54 am

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Announces First-Ever Trial to Treat COVID-19 Frontline Clinicians, Unveils EMBARK Model

The study will examine treating symptoms of depression, anxiety, burnout and post-traumatic stress EMBARK is groundbreaking psychotherapy model that integrates leading clinical approaches to promote supportive healing with psychedelic medicine Cybin considers it an honor, duty to support healing processes of doctors, nurses and healthcare professionals, says CEO In the first-ever study of its kind, Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, has announced that it is co-sponsoring a study focused on treating frontline clinicians experiencing COVID-related distress (https://ibn.fm/NvMAo). In addition to co-sponsoring the study, Cybin also announced the development of EMBARK, a groundbreaking…

ThursdayJun 17, 2021 9:00 am

Brain Scientific Inc. (BRSF) Poised to Contribute to Mental Health Research; Provides Technology to Map Brain Response to Psychedelic Treatment

BRSF has partnered with Ehave to conduct research connected to biochemical biomarkers concerning psychedelic drug administration Psychedelic drugs show promise in treating neurological disorders, including chronic pain, depression, and PTSD, but more research is needed BRSF's E-Tattoo is poised to bring benefits of biomarkers to neurological and psychiatric research; allows monitoring of patient's brain activity in a non-intrusive way Brain Scientific (OTCQB: BRSF) has partnered with Ehave, Inc., a provider of digital therapeutics for the psychedelic and mental health sectors, to use data and AI algorithms to statistically correlate biomarkers for the identification of psychedelic drug administration as a treatment…

WednesdayJun 16, 2021 10:40 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Presentation to Provide Overview of Psychedelic Drug Candidate Program at Ladenburg Thalmann Healthcare Conference

Tryp Therapeutics is a development-stage pharmaceutical company dedicated to finding novel bioscience solutions for conditions with unmet needs The company’s executive team will present an overview of its Psilocybin-For-Neuropsychiatric Disorders (“PFN”) program, in response to conditions such as fibromyalgia, at next month’s Ladenburg Thalmann Healthcare Conference Tryp’s synthetic psychedelic drug candidate will be further developed in an upcoming phase 2a clinical study in partnership with pediatric eating disorders expert Jennifer Miller, M.D. at the University of Florida The trial will focus on Tryp’s flagship candidate, TRP-8802, in treating binge eating and hypothalamic obesity The company expects to begin manufacturing its…

TuesdayJun 15, 2021 2:35 pm

Study Finds Coronavirus Pandemic Significantly Impacted Adolescents’ Mental Health

A study carried out by a group of social and behavioral researchers from North America and Iceland has discovered that the coronavirus has had a harmful effect on adolescent mental health, particularly in girls. This study is the first to look into and record the gender and age-specific changes in adolescent substance use and mental health issues during the coronavirus pandemic, while taking into consideration the trends observed prior to the pandemic. The researchers’ findings were reported in the “Lancet Psychiatry” journal. The researchers discovered that in comparison with same-age peers before the pandemic, negative mental health outcomes were disproportionately…

TuesdayJun 15, 2021 1:22 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Commences Sale of Rapid COVID-19 RT-PCR Test Kits in Germany Amid Potential Surge in Demand

XPhyto’s distribution, storage, and logistics partner, Max Pharma GmbH, began the sale and delivery of its rapid test kits (Covid-ID Labs) in Germany on May 25 Max Pharma will sell Covid-ID Labs at volume-dependent pricing comparable to other COVID-19 PCR test products on the market The announcement comes as Germany reopens, meaning XPhyto is likely to benefit from a raft of regulatory requirements instituted by the government, which could potentially increase demand The Covid-ID Labs is both fast and accurate, factors that could make it the go-to product, given the inaccuracies and low sensitivity of many rapid antigen tests As…

TuesdayJun 15, 2021 9:15 am

Brain Scientific Inc. (BRSF) Tech to be Used in a Ketamine Clinical Study for Mental Health Care

Ehave announced it will utilize BRSF's tech in an upcoming ketamine clinical study BRSF's tech will make it possible to correlate biomarkers for the identification of chronic pain, depression, PTSD, bipolar disorder, and more. The data from this clinical trial has the potential to provide longitudinal insights that can link brain analysis and psychedelics Brain Scientific (OTCQB: BRSF), a commercial-stage health care company, is on a mission to modernize brain diagnostics with cutting-edge tech that bridges the widening gap in access to quality care. The company's technology will be part of a ketamine clinical study conducted by Ehave, Inc. (OTC:…

MondayJun 14, 2021 3:10 pm

Study Discovers That Major Depressive Disorder Increases Healthcare Burden

According to recently released research, patients who suffer from inflammatory bowel disease and major depressive disorder have higher healthcare burdens and discharge rates, as well as increased morbidity. Major depressive disorder, which is sometimes referred to as clinical depression, affects an individual’s behavior and mood as well as physical functions such as sleep and appetite. This disorder is a common mental health condition in the United States, with data suggesting that more than 7% of adults in the country experience depressive episodes. On the other hand, inflammatory bowel disease represents various intestinal ailments that bring about prolonged inflammation of an…

MondayJun 14, 2021 9:58 am

DGE’s 2nd Medical Writing Innovation Strategies Conference for Life Sciences

Date: June 29-30, 2021Online Livestream Event Biopharma medical writing and communications professionals are invited are invited to attend DGE’s 2nd Medical Writing Innovation Strategies Conference for Life Sciences live streaming on June 29-30, 2021. The event will offer useful tips and guide medical professionals to learn innovative skills for filtering technical information that is effectively communicated for engagement. These power-packed sessions will assist medical writers and communicators in elevating their skills that will, in turn, boost their career growth. With the increasing pressure on medical writing, professionals will learn how to diffuse work stress and communicate harmoniously in the work…

MondayJun 14, 2021 9:00 am

Healthy Extracts Inc. (HYEX) Stands Distinct in the Development, Provision of Highest-Quality Supplements with Proven Health Benefits

HYEX’s portfolio of wholly owned subsidiaries currently comprises BergametNA and Ultimate Brain Nutrients BergametNA, whose products target cardiovascular and immune health, sources its formulations from the Citrus Bergamot SuperFruit(TM) The bergamot fruit is richly packed with polyphenolic flavanones, which are known to decrease bad cholesterol, triglyceride, and glucose, as well as increase the good cholesterol BergaMet only uses the highest concentration of polyphenolic flavanones (“BPF”) as the higher the BPF, the greater the effectiveness of the supplement Guided by the philosophy ‘Live Life Young Again’ and its commitment to superior health technology by engaging in the R&D of natural plant-based…

FridayJun 11, 2021 12:15 pm

Fibromyalgia and the Future of Telehealth

Fibromyalgia is an acute illness that can present as cognitive dysfunction, lack of energy, intense fatigue and abnormal pain among other symptoms. Sometimes, individuals who suffer from this condition may experience flares, when their symptoms get too intense. This makes it harder for them to perform simple tasks, even struggling to make it to doctor’s appointments. However, the coronavirus pandemic and improvements in technology have made it possible for fibromyalgia patients to access telehealth appointments, which allows them to talk with their doctor remotely, either via tablet, phone or computer, while they’re home. Patients can now schedule telehealth appointments with…

News and publishing service for medical and biotechnology related companies

Contact us: 415.949.5050

Month: June 2021

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Announces First-Ever Trial to Treat COVID-19 Frontline Clinicians, Unveils EMBARK Model

Brain Scientific Inc. (BRSF) Poised to Contribute to Mental Health Research; Provides Technology to Map Brain Response to Psychedelic Treatment

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Presentation to Provide Overview of Psychedelic Drug Candidate Program at Ladenburg Thalmann Healthcare Conference

Study Finds Coronavirus Pandemic Significantly Impacted Adolescents’ Mental Health

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Commences Sale of Rapid COVID-19 RT-PCR Test Kits in Germany Amid Potential Surge in Demand

Brain Scientific Inc. (BRSF) Tech to be Used in a Ketamine Clinical Study for Mental Health Care

Study Discovers That Major Depressive Disorder Increases Healthcare Burden

DGE’s 2nd Medical Writing Innovation Strategies Conference for Life Sciences

Healthy Extracts Inc. (HYEX) Stands Distinct in the Development, Provision of Highest-Quality Supplements with Proven Health Benefits

Fibromyalgia and the Future of Telehealth

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search